This statistic shows a distribution of biotechnology companies' capital flow in Europe from 2008 to 2020. In 2020, European biotech companies were able to acquire venture capital amounting to roughly 3.9 billion euros.
Distribution of biotechnology companies' capital flow in Europe from 2008 to 2020
(in billion euros)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
EY. (April 19, 2021). Distribution of biotechnology companies' capital flow in Europe from 2008 to 2020 (in billion euros) [Graph]. In Statista. Retrieved May 23, 2022, from https://www.statista.com/statistics/580002/capital-inflow-biotechnology-companies-europe/
EY. "Distribution of biotechnology companies' capital flow in Europe from 2008 to 2020 (in billion euros)." Chart. April 19, 2021. Statista. Accessed May 23, 2022. https://www.statista.com/statistics/580002/capital-inflow-biotechnology-companies-europe/
EY. (2021). Distribution of biotechnology companies' capital flow in Europe from 2008 to 2020 (in billion euros). Statista. Statista Inc.. Accessed: May 23, 2022. https://www.statista.com/statistics/580002/capital-inflow-biotechnology-companies-europe/
EY. "Distribution of Biotechnology Companies' Capital Flow in Europe from 2008 to 2020 (in Billion Euros)." Statista, Statista Inc., 19 Apr 2021, https://www.statista.com/statistics/580002/capital-inflow-biotechnology-companies-europe/
EY, Distribution of biotechnology companies' capital flow in Europe from 2008 to 2020 (in billion euros) Statista, https://www.statista.com/statistics/580002/capital-inflow-biotechnology-companies-europe/ (last visited May 23, 2022)
